Woodmont Investment Counsel LLC lifted its holdings in shares of National Health Investors, Inc. (NYSE:NHI – Free Report) by 8.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 136,697 shares of the real estate investment trust’s stock after acquiring an additional 10,852 shares during the period. Woodmont Investment Counsel LLC owned 0.28% of National Health Investors worth $8,971,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in NHI. Versant Capital Management Inc increased its stake in National Health Investors by 108.5% in the 3rd quarter. Versant Capital Management Inc now owns 415 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 216 shares during the period. Compass Wealth Management LLC acquired a new position in National Health Investors in the third quarter valued at $31,000. Allworth Financial LP acquired a new stake in shares of National Health Investors during the 2nd quarter worth $42,000. GAMMA Investing LLC grew its stake in National Health Investors by 38.0% during the third quarter. GAMMA Investing LLC now owns 603 shares of the real estate investment trust’s stock worth $40,000 after buying an additional 166 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in National Health Investors by 34.3% in the first quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock valued at $51,000 after acquiring an additional 160 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.
National Health Investors Trading Down 0.0%
National Health Investors stock opened at $67.02 on Monday. National Health Investors, Inc. has a 1 year low of $63.51 and a 1 year high of $91.38. The firm’s 50-day moving average is $68.10 and its 200-day moving average is $76.41. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The company has a market cap of $3.29 billion, a P/E ratio of 19.37, a PEG ratio of 4.27 and a beta of 0.49.
National Health Investors (NYSE:NHI – Get Free Report) last released its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The business had revenue of $121.32 million for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm’s revenue was up 1.6% on a year-over-year basis. During the same period last year, the business earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities analysts expect that National Health Investors, Inc. will post 4.76 earnings per share for the current year.
National Health Investors Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.5%. National Health Investors’s payout ratio is currently 108.67%.
Analyst Ratings Changes
A number of analysts recently issued reports on NHI shares. Weiss Ratings lowered shares of National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, September 25th. Wells Fargo & Company decreased their price objective on shares of National Health Investors from $78.00 to $68.00 and set an “equal weight” rating for the company in a report on Monday, October 19th. Zacks Research upgraded shares of National Health Investors from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 29th. Huntington started coverage on National Health Investors in a research note on Thursday, September 10th. They issued an “outperform” rating and a $79.00 price target for the company. Finally, BMO Capital Markets reissued an “outperform” rating on shares of National Health Investors in a report on Wednesday, September 23rd. Five investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $81.00.
Get Our Latest Analysis on NHI
National Health Investors Company Profile
National Health Investors, Inc (NYSE:NHI) is a real estate investment trust that owns and finances income-producing healthcare real estate in the United States. The company primarily focuses on properties serving older adults and patients who require specialized care.
NHI’s portfolio includes independent living communities, assisted living and memory care facilities, skilled nursing facilities, continuing care retirement communities, medical office buildings and other healthcare-related properties.
Recommended Stories
- Five stocks we like better than National Health Investors
- SK hynix Says Memory Demand Beats Supply Through 2030—What It Means for Micron and SanDisk
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
